Literature DB >> 3524652

Beyond randomised controlled trials: the case for effective case studies of the effects of treatment in aphasia.

D Howard.   

Abstract

Entities:  

Mesh:

Year:  1986        PMID: 3524652     DOI: 10.3109/13682828609018546

Source DB:  PubMed          Journal:  Br J Disord Commun        ISSN: 0007-098X


× No keyword cloud information.
  8 in total

Review 1.  Trials and tribulations in speech therapy.

Authors:  C M Allen
Journal:  BMJ       Date:  1990-08-11

2.  The case for single-case studies in treatment research-comments on Howard, Best and Nickels "Optimising the design of intervention studies: critiques and ways forward".

Authors:  Nadine Martin; Michelene Kalinyak-Fliszar
Journal:  Aphasiology       Date:  2014-12-24       Impact factor: 2.773

3.  Challenges in the use of treatment to investigate cognition.

Authors:  Lyndsey Nickels; Brenda Rapp; Saskia Kohnen
Journal:  Cogn Neuropsychol       Date:  2015       Impact factor: 2.468

Review 4.  Poststroke aphasia : epidemiology, pathophysiology and treatment.

Authors:  Marcelo L Berthier
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  Plasticity, permanence, and patient performance: study design and data analysis in the cognitive rehabilitation of acquired communication impairments.

Authors:  Patricia E Cowell; Sandra P Whiteside; Fay Windsor; Rosemary A Varley
Journal:  Front Hum Neurosci       Date:  2010-11-26       Impact factor: 3.169

6.  The Long View of Language Localization.

Authors:  Marjorie Perlman Lorch
Journal:  Front Neuroanat       Date:  2019-05-24       Impact factor: 3.856

7.  On the use of different methodologies in cognitive neuropsychology: drink deep and from several sources.

Authors:  Lyndsey Nickels; David Howard; Wendy Best
Journal:  Cogn Neuropsychol       Date:  2011-10       Impact factor: 2.468

Review 8.  Neurobiological, cognitive, and emotional mechanisms in melodic intonation therapy.

Authors:  Dawn L Merrett; Isabelle Peretz; Sarah J Wilson
Journal:  Front Hum Neurosci       Date:  2014-06-02       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.